The ALS Association
27001 Agoura Road, Suite 150
53 articles with The ALS Association
ALS Advocates Secure Rare Bipartisan Support for End to Five-Month Wait for Social Security Disability Insurance
Congress passed a law ending the five-month waiting period for people with ALS to access Social Security Disability Insurance benefits on Tuesday.
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt "Patient-First" Policy Agenda
A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort by releasing their top priorities for the next Administration.
In response to the New England Journal of Medicine publication of encouraging clinical trial results showing that Amylyx Pharmaceuticals' AMX0035 brought statistically significant benefit to people living with ALS, The ALS Association and I AM ALS immediately called on the drug company and the FDA to make the treatment widely available as soon as possible.
The ALS Association and I AM ALS announced that the organizations have awarded a combined grant of $500,000 to BrainStorm Cell Therapeutics, a biotechnology company, to support an amyotrophic lateral sclerosis biomarker research study.
The ALS Association Awards Bloom Science to Develop Novel Gut Microbiota-based Therapies for Amyotrophic Lateral Sclerosis (ALS)
Bloom Science, a biopharmaceutical company focused on the discovery and development of medicines tailored for individual patients living with neurological diseases, has received a $500,000 grant from The ALS Association.
The ALS Association announced a $3 million commitment to the first platform trial for ALS, taking place at the Sean M. Healey & AMG Center for ALS at Mass General in collaboration with the Barrow Neurological Institute and the Northeast ALS Consortium.
New ALS Association Partnership with ALS Investment Fund Targets $100 Million in New Funding for ALS Therapeutic Development
The ALS Association is partnering with, and will be directly investing in, the ALS Investment Fund II to raise $100 million to accelerate investment in ALS research and development.
New report shows significant increases in ALS research spending, researchers funded, collaborations, dollars leveraged
GNS Healthcare to combine its powerful, causal machine learning technology with the comprehensive Answer ALS patient datasets
Researchers have identified a new ALS gene: KIF5A.
Researchers Demonstrate Therapeutic Antibodies Stabilize Nerve-Muscle Synapses in a Mouse Model of ALS
Research funded by The ALS Association's Lawrence and Isabel Barnett Drug Development Program recently uncovered a new way to slow muscle paralysis in mice with ALS, findings that could point to new approaches to therapy for people with ALS.
The ALS Association And ALS Finding A Cure Announce Joint Funding Support For Amylyx Clinical Trial Of AMX0035 For The Treatment Of ALS
The ALS Association Release: Professor Ammar Al-Chalabi Receives The 2016 Sheila Essey Award For ALS Research
The ALS Association Awards Origent Data Sciences A Grant To Enable A Research Partnership With Cytokinetics
The ALS Association And Prize4Life Announce First Phase Winners Of The ALS Assistive Technology Challenge, Launch $400,000 Prize Phase